The standard management of benign prostatic hyperplasia is based on the overall health of the patient, on the severity of the lower urinary tract symptoms and on quality-of-life considerations. Voiding difficulties attributable to hyperplasia can be quantified with the International Prostate Symptom Score (IPSS). Various medications can decrease the severity of voiding symptoms secondary to benign prostatic hyperplasia. Impotence, decreased libido and ejaculatory disorders are known side effects.
PARIS -- More dramatic blood pressure reductions may be on the horizon for patients with resistant hypertension given the phalanx of renal denervation systems under development.
AngioDynamics (Nasdaq:ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced it has completed its acquisition of Navilyst Medical. Based on yesterday s closing price of $12.44 the transaction is valued at $355 million. The combination of the two companies is expected to double AngioDynamics share of the vascular access market, build critical mass in the peripheral vascular market and establish a strong operating platform for future growth.
SIR-Spheres® microspheres are well-tolerated and effective internal radiotherapy for unresectable, heavily pre-treated colorectal cancer liver metastases, according to results from a new study of more than 600 patients presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. The data were presented by lead investigator Andrew Kennedy, M.D., FACRO, from Cancer Centers of North Carolina and North Carolina State University. SIR-Spheres microspheres are manufactured by Sirtex and are the only fully FDA-approved microsphere radiation therapy for the treatment of colorectal liver metastases.
A filter used to block clots from passing from the veins in the legs to the arteries of the lung does not improve mortality rates for most patients suffering a pulmonary embolism. However, if a patient is unstable – in shock or requires a ventilator – filters can save lives. Furthermore, for unstable patients with a pulmonary embolism, it is crucial they receive clot-dissolving medications known as thrombolytic therapy.
ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today the first successful procedure in the United States with CT-Guide™ navigation. The procedure was performed by Sebastian Flacke, M.D., Ph.D., Director of Interventional Radiology and Vice Chair for Research at the Lahey Clinic in Burlington, Massachusetts. Dr. Flacke utilized CT-Guide™ navigation for a successful lung biopsy of a small, deep abnormality in the patient’s middle right lobe.
Ultrasonix Medical Corporation has received CE certification for its SonixGPS technology for Regional Anesthesia and Vascular Access, which will be immediately available in all countries that are part of the European Community. First approved for use in Canada, the SonixGPS technology has been used in hospitals in British Columbia and Ontario since October 2011. Clinical studies have proven the accuracy and clinical benefits of using the new technology for guidance procedures such as nerve blocks for regional anesthesia, and pain management and vascular access procedures which deliver medications into a patient’s bloodstream.
W. L. Gore & Associates, Inc. (Gore) today announced that it has extended its distribution agreement in the US and Canada with ConMed Endoscopic Technologies for the distribution and marketing of its GORE(R) VIABIL(R) Biliary Endoprosthesis. "We are very excited to announce this exclusive contract extension with ConMed," said Gore Medical Products Business Leader, Ron Anderson. "This will assure that interventional gastroenterologists have increasing access to the GORE VIABIL Biliary Endoprosthesis, which has the proven clinical benefits of low migration and long-term patency." "Over the past several years, GORE VIABIL Biliary Endoprosthesis, with its cadre of technological benefits, has assisted the GI community in delivering enhanced patient outcomes," said Mark Donovan, Vice President of ConMed Endoscopic Technologies.
Two new denervation systems were launched at EuroPCR (Paris, 15–18 May 2012). Covidien unveiled its OneShot system and St Jude Medical announced the launch of the EnligHTN system. Both systems are designed to treat patients with hypertension who are not responsive to traditional medical therapy.
Cordis has announced the launch of the Powerflex Pro .035” percutaneous transluminal angioplasty (PTA) dilatation catheter in Europe for the treatment of peripheral vascular disease in the lower extremities.
The percutaneous embolization of varicocele requires which selective catheterisation of the internal spermatic vein(s) followed by its (their) occlusion with either a sclerosant or solid embolic devices came in for discussion at the GEST 2012 US meeting.
An animal study using a porcine model has identified some of the sequelae of gastric artery embolization for systemic suppression of the hunger hormone, ghrelin. Ghrelin levels may be reduced by embolizing its production centres in the gastric fundus; however, incomplete fundal embolization and concerns for non-target embolization remain obstacles to the success of the procedure, say researchers.
BiO2 Medical has announced that it has received CE mark approval for the Angel Catheter, a nitinol inferior vena cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing pulmonary embolism in critically ill patients with venous thromboembolism for whom anticoagulation therapy is temporarily contraindicated.
ViewRay has received US FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features a combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer. ViewRay s treatment planning and delivery software received 510(k) premarket notification clearance in 2011.
At ECIO 2012, David J Breen, Department of Radiology, University of Southampton School of Medicine, UK, shared with delegates 10 top tips for optimising outcomes in microwave ablation of the liver. The talk was part of a satellite symposium supported by Microsulis Medical.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos